Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 162 | 125 | 125 | 125 | 362 |
| Accounts receivable | 8 | -1 | -2 | -2 | 0 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -76 | 36 |
| Other Working Capital | 0 | 4 | -42 | -86 | -25 |
| Other Operating Activity | -183 | -208 | -252 | -126 | -505 |
| Operating Cash Flow | $-13 | $-80 | $-171 | $-165 | $-133 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 8 | 0 | 0 | 1,230 |
| Investing Cash Flow | $N/A | $8 | $N/A | $N/A | $1,230 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 6 | 0 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | -485 |
| Other Financing Activity | -129 | -6 | 0 | 0 | -476 |
| Financing Cash Flow | $-129 | $-6 | $6 | $0 | $-961 |
| Beginning Cash Position | 172 | 249 | 532 | 697 | 561 |
| End Cash Position | 139 | 172 | 249 | 532 | 697 |
| Net Cash Flow | $-33 | $-78 | $-283 | $-165 | $136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13 | -80 | -171 | -165 | -133 |
| Free Cash Flow | -13 | -80 | -171 | -165 | -133 |